Babett Steglich

Babett Steglich is a researcher at the I. Medical Clinic and Polyclinic of Universitätsklinikum Hamburg-Eppendorf (UKE), where she focuses on immunology, inflammation, and liver diseases. With a Dr. phil. degree, she has established herself as a significant contributor to research in autoimmune disorders, particularly in the context of inflammatory bowel disease and liver conditions.

Her research interests span multiple areas of immunology with a focus on:

• Immune regulation in inflammatory bowel diseases
• Liver-gut axis interactions in autoimmune conditions
• T cell biology, particularly Th17 and regulatory T cells
• Cytokine signaling in liver diseases and cancer
• Immune mechanisms in liver metastasis and hepatocellular carcinoma

Over the past several years, Dr. Steglich's work has primarily examined the complex interplay between the immune system and liver diseases, with particular emphasis on how inflammatory processes in the gut affect liver conditions and vice versa. Her research has significant implications for understanding autoimmune disorders and developing targeted immunotherapies.

Dr. Steglich has contributed to numerous publications in high-impact journals including Gut, Journal of Hepatology, and Nature Immunology. Her work demonstrates consistent productivity with multiple publications each year from 2017 through 2024.

She actively collaborates with a multidisciplinary team of researchers led by principal investigators including Samuel Huber and Nicola Gagliani, contributing to a robust research program focused on translational immunology with clinical applications.